Company / EPS (Diluted)
Silo Pharma, Inc. EPS (Diluted) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.19
FY2025
5-year range
-$1.20 / -$0.02
FY2021-FY2025
Trend
+0.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) returned to growth in FY2025 after 2 years of decline, reaching $-1.19.
Based on SEC 10-K filings.
-1.19 in FY2025.
Declined from $-0.04 to $-1.19 over the past 5 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 0.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.19 | +0.8% |
| FY2024 | -$1.20 | - |
| FY2023 | - | - |
| FY2020 | -$0.04 | -100.0% |
| FY2019 | -$0.02 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026